This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Becker, Michael
Item Type | Name |
Concept
|
Enzyme Inhibitors
|
Academic Article
|
Update on emerging urate-lowering therapies.
|
Academic Article
|
Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers.
|
Academic Article
|
Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics.
|
Academic Article
|
Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase.
|
Academic Article
|
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
|
Academic Article
|
Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.
|
Academic Article
|
Diabetes and gout: efficacy and safety of febuxostat and allopurinol.
|